Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behnaz Lahooti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmaceutics|December 23, 2022
Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug DeliveryArchana Shrestha, Behnaz Lahooti, Constantinos M Mikelis, et al.
Frontiers in Oncology|December 27, 2021
MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and PotentialBehnaz Lahooti, Sagun Poudel, Constantinos M Mikelis, et al.
Journal of Biomedical Materials Research. Part A|June 1, 2016
Modeling and optimization of antibacterial activity of the chitosan-based hydrogel films using central composite designBehnaz Lahooti, Mohammad Khorram, Gholamreza Karimi, et al.
Brain, Behavior, and Immunity|November 6, 2020
Therapeutic role of inflammasome inhibitors in neurodegenerative disordersBehnaz Lahooti, Tanya Chhibber, Sounak Bagchi, et al.
Drug Design, Development and Therapy|November 8, 2019
In-vitro blood-brain barrier models for drug screening and permeation studies: an overviewSounak Bagchi, Tanya Chhibber, Behnaz Lahooti, et al.
International Journal of Molecular Sciences|April 27, 2024
Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle ProgressionArchana Shrestha, Behnaz Lahooti, A K M Nawshad Hossian, et al.
Drug Discovery Today|November 30, 2019
CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screeningTanya Chhibber, Sounak Bagchi, Behnaz Lahooti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2023
Targeting endothelial permeability in the EPR effectBehnaz Lahooti, Racheal G Akwii, Fatema Tuz Zahra, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2023
Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated NanoparticlesBehnaz Lahooti, Racheal G Akwii, Dhavalkumar Patel, et al.
Lab on a Chip|August 5, 2020
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and applicationTaslim A Al-Hilal, Ali Keshavarz, Hossam Kadry, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmaceutics|December 23, 2022
Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug DeliveryArchana Shrestha, Behnaz Lahooti, Constantinos M Mikelis, et al.
Frontiers in Oncology|December 27, 2021
MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and PotentialBehnaz Lahooti, Sagun Poudel, Constantinos M Mikelis, et al.
Journal of Biomedical Materials Research. Part A|June 1, 2016
Modeling and optimization of antibacterial activity of the chitosan-based hydrogel films using central composite designBehnaz Lahooti, Mohammad Khorram, Gholamreza Karimi, et al.
Brain, Behavior, and Immunity|November 6, 2020
Therapeutic role of inflammasome inhibitors in neurodegenerative disordersBehnaz Lahooti, Tanya Chhibber, Sounak Bagchi, et al.
Drug Design, Development and Therapy|November 8, 2019
In-vitro blood-brain barrier models for drug screening and permeation studies: an overviewSounak Bagchi, Tanya Chhibber, Behnaz Lahooti, et al.
International Journal of Molecular Sciences|April 27, 2024
Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle ProgressionArchana Shrestha, Behnaz Lahooti, A K M Nawshad Hossian, et al.
Drug Discovery Today|November 30, 2019
CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screeningTanya Chhibber, Sounak Bagchi, Behnaz Lahooti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2023
Targeting endothelial permeability in the EPR effectBehnaz Lahooti, Racheal G Akwii, Fatema Tuz Zahra, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2023
Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated NanoparticlesBehnaz Lahooti, Racheal G Akwii, Dhavalkumar Patel, et al.
Lab on a Chip|August 5, 2020
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and applicationTaslim A Al-Hilal, Ali Keshavarz, Hossam Kadry, et al.
Pageof 2